Sign in
Not yet taking people in IrelandPhase 4

Weight loss programme with or without medicine for women with obesity and infertility

Tests a weight programme, with or without medicine, in women with obesity and infertility.

Key facts

Who runs it
University College Dublin
Where
Dublin 4, IrelandSee the site
Registry title
PREconception weight management Programme to Achieve weight Reduction and Enhance fertility (PREPARE)
Status
Not yet recruiting
Phase
Phase 4
People taking part
60 people, planned
Started
2 Nov 2026
Expected to end
1 Aug 2029
Type of study
Interventional
Record updated
30 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with obesity who have had trouble getting pregnant. It tests a weight loss medicine plus a digital programme against the digital programme alone.

Age
Women aged 18-39 years
Sex
Women only
Disease stage
BMI 30-40 kg/m2. Trying to conceive for more than 12 months if under 36 years old, or more than 6 months if 36 or older.
Earlier treatment
Fertility assessments completed within the previous 6 months.

Main reasons for not taking part

  • Currently pregnant or breastfeeding
  • Known allergy or reason not to take the trial medicine
  • Taking part in another trial of a medicine
  • Unwilling or unable to give informed consent

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Women aged 18-39 years
  • BMI 30-40 kg/m2
  • Trying to conceive for > 12 months if under 36 years of age, or for > 6 months if aged 36 years of age or over and have had fertility assessments completed within the previous 6 months
  • Meet the following HSE criteria for fertility treatment
  • Agreeable to contraceptive use if allocated to the intervention group
  • Meet study eligibility criteria
  • Willing and able to give informed consent

Who cannot take part

  • Concurrent participation in another investigational medicinal product study, although participants will not be excluded from other observational studies provided the other observational studies have no interventions
  • Known hypersensitivity or contraindication to the intervention medication
  • Current pregnancy or breastfeeding
  • Unwilling or unable to give informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Ireland

  • St Vincent's University HospitalDublin 4, IrelandNot yet recruiting

About the trial

What the trial wants to find out

The primary objective is to assess the feasibility and acceptability of combining pharmacotherapy with a digitally delivered behaviour change intervention, compared with behaviour change alone, to support weight loss and improve fertility in women living with obesity and infertility.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
A feasibility randomised controlled trial of a weight management programme for women living with obesity and infertility
Plain-language title
Weight loss programme with or without medicine for women with obesity and infertilityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2026-526869-19-00, who can take part
Record updated
30 October 2026